15 results found.

Autism Spectrum Disorders Clinical Trial using Vasopressin; Placebo

Stanford University - Recruiting 6 years to 12 years.
- Randomized Placebo-controlled Trial of Vasopressin Treatment for Social Deficits in Children With Autism.
Vasopressin; Placebo

Autism Spectrum Disorders Clinical Trial

Children's Hospital Medical Center, Cincinnati - Recruiting 3 years to 25 years.
- Extracellular Signal-Related Kinase Biomarker Development in Autism.

Autism Spectrum Disorders Clinical Trial using Riluzole; placebo

Children's Hospital Medical Center, Cincinnati - Recruiting 12 years to 26 years.
- A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders.
Riluzole; placebo

Autism, Language Acquisition, Language Development, or Toddlers Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 10 Months to 20 Months.
- Markers of Autism Spectrum Disorders in At-Risk Toddlers: A Pilot Study.

Autism Spectrum Disorders Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A to 20 years.
- Screening Protocol for Studies of the Pediatrics and Developmental Neuroscience Branch.

Autism Spectrum Disorders Clinical Trial using Provider Education Model (PEM)

Hugo W. Moser Research Institute at Kennedy Krieger, Inc. - Recruiting 24 Months to 42 Months.
- Improving Part C Services and Outcomes for Under-resourced Children With ASD.
Provider Education Model (PEM)

Attention Deficit Disorder With Hyperactivity, Attention Deficit Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 4 years to 8 years.
- Near Infra-Red Spectroscopy (NIRS) in Neurodevelopmental Disorders and Typically Developing Children.

Autism Spectrum Disorders, Brain Disease, Autism, or Healthy Volu Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 45 years.
- Neuroimmune Activation in Austism: Imaging Translocator Protein Using Positron Emission Tomography (PET).

Autism Spectrum Disorder, Obsessive Compulsive Disorder, Pediatri Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Diagnosis and Treatment of Childhood-onset Behavioral Disorders, Neuropsychiatric Disorders and Neurodevelopmental Disorders.

Autism Spectrum Disorders Clinical Trial using Donepezil; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 24 Months to 50 Months.
- A Randomized Controlled Trial of Donepezil for REM Enhancement and Behavioral Change in Autism.
Donepezil; Placebo

Autism Spectrum Disorders Clinical Trial using Sham OMM; Osteopathic Manual Medicine (Body Therapy)

New York Institute of Technology - Recruiting 3 years to 8 years.
- Osteopathic Manual Medicine Treatment in Autism, A Pilot Study.
Sham OMM; Osteopathic Manual Medicine (Body Therapy)

Autism Spectrum Disorders, Autism, Asperger's Syndrome, Pervasive Clinical Trial using Personalized Cognitive-behavioral therapy; Standard Practice Cognitive-behavioral therapy

University of South Florida - Recruiting 8 years to 13 years.
- 2/3 Treatment of Anxiety in Autism Spectrum Disorder.
Personalized Cognitive-behavioral therapy; Standard Practice Cognitive-behavioral therapy

Autism Clinical Trial using Trichuris Suis Ova

Montefiore Medical Center - Recruiting 18 years to 35 years.
- Trichuris Suis Ova in Autism Spectrum Disorders.
Trichuris Suis Ova

Autism Spectrum Disorders, or Schizophrenia Clinical Trial using Neuropsychological evaluation

University Hospital, Strasbourg, France - Recruiting 7 years to 55 years.
- Visual Exploration and Attention : Studies in Patients With Schizophrenia and Autism Spectrum Disorders.
Neuropsychological evaluation

Autism, or ASD Clinical Trial using Syntocinon

Bartz, Jennifer, Ph.D. - Recruiting 18 years to 45 years.
- The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders.
Syntocinon